Volastra Therapeutics
New York, United States· Est.
Volastra Therapeutics develops therapies targeting chromosomal instability for cancer treatment.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $60M
About
Volastra Therapeutics develops therapies targeting chromosomal instability for cancer treatment.
OncologyGenetics & Genomics
Funding History
1Total raised:$60M
Series A$60M